Cargando…
Antigen-based multiplex strategies to discriminate SARS-CoV-2 natural and vaccine induced immunity from seasonal human coronavirus humoral responses
Sensitive and specific SARS-CoV-2 antibody assays remain critical for community and hospital-based SARS-CoV-2 sero-surveillance. With the rollout of SARS-CoV-2 vaccines, such assays must be able to distinguish vaccine from natural immunity to SARS-CoV-2 and related human coronaviruses. Here, we deve...
Autores principales: | Laing, Eric D., Sterling, Spencer L., Richard, Stephanie A., Epsi, Nusrat J., Coggins, Si’Ana, Samuels, Emily C., Phogat, Shreshta, Yan, Lianying, Moreno, Nicole, Coles, Christian L., Drew, Matthew, Mehalko, Jennifer, English, Caroline E., Merritt, Scott, Mende, Katrin, Munster, Vincent J., de Wit, Emmie, Chung, Kevin K., Millar, Eugene V., Tribble, David R., Simons, Mark P., Pollett, Simon D., Agan, Brian K., Esposito, Dominic, Lanteri, Charlotte, Clifton, G. Travis, Mitre, Edward, Burgess, Timothy H., Broder, Christopher C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885935/ https://www.ncbi.nlm.nih.gov/pubmed/33594376 http://dx.doi.org/10.1101/2021.02.10.21251518 |
Ejemplares similares
-
A betacoronavirus multiplex microsphere immunoassay detects early SARS-CoV-2 seroconversion and antibody cross reactions
por: Laing, Eric, et al.
Publicado: (2020) -
A betacoronavirus multiplex microsphere immunoassay detects early SARS-CoV-2 seroconversion and controls for pre-existing seasonal human coronavirus antibody cross-reactivity
por: Laing, Eric D., et al.
Publicado: (2020) -
Clinical, Immunological, and Virological SARS-CoV-2 Phenotypes in Obese and Nonobese Military Health System Beneficiaries
por: Epsi, Nusrat J, et al.
Publicado: (2021) -
SARS-CoV-2 Infections and Serologic Responses Among Military Personnel Deployed on the USNS COMFORT to New York City During the COVID-19 Pandemic
por: Lalani, Tahaniyat, et al.
Publicado: (2021) -
SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum, but evades most convalescent serum and therapeutic antibodies
por: Lusvarghi, Sabrina, et al.
Publicado: (2022)